This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cabergoline and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (130)
Death (6)
Life Threatening Events (5)
Disability (8)
Reports by Reaction Type
Pneumocephalus (11),
Neoplasm Progression (9),
Visual Pathway Disorder (9),
Drug Interaction (8),
Headache (6),
Pathological Gambling (6),
Psychiatric Symptom (6),
Visual Field Defect (6),
Drug Ineffective (5),
Hypersexuality (5),
Prolactinoma (5),
Tachyphylaxis (5)
Below are a few examples of reports where side effects / adverse reactions may be related to Cabergoline. For a complete list or a specific selection of reports, please use the links above.
Possible Cabergoline side effects in 70 year old female
Reported by a physician from Japan on 2012-08-27
Patient: 70 year old female, weighing 53.5 kg (117.7 pounds)
Reactions: Coronary Artery Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Therapy
Dosage: double blind (5mg or placebo) (1 in 1 d)
Administration route: Oral
Start date: 2011-10-20
Blinded Therapy
Dosage: double blind (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-10-12
End date: 2011-10-19
Brotizolam
Dosage: 0.25 mg, 1x/day
Administration route: Oral
Indication: Insomnia
Start date: 2011-04-14
Cabergoline
Dosage: 0.5 mg, 1x/day
Administration route: Oral
Indication: Parkinson's Disease
Carbidopa
Dosage: unk
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2007-07-10
Clonazepam
Dosage: 1 mg, 1x/day
Administration route: Oral
Indication: Insomnia
Start date: 2007-01-01
Comtan
Dosage: 100 mg, 3x/day
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2009-06-15
Famotidine
Dosage: 20 mg, 1x/day
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-05-06
Flurbiprofen
Dosage: unk
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2008-06-19
Gasmotin
Dosage: 5 mg, 2x/day
Administration route: Oral
Indication: Prophylaxis
Magmitt
Dosage: 1650 mg, 3x/day
Administration route: Oral
Indication: Constipation
Start date: 2007-01-01
Symmetrel
Dosage: 50 mg, 2x/day
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2009-12-21
Tizanidine Hydrochloride
Dosage: 1 mg, 3x/day
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2007-12-20
Other drugs received by patient: Digoxin
Possible Cabergoline side effects in 70 year old female
Reported by a physician from Japan on 2012-08-15
Patient: 70 year old female, weighing 53.5 kg (117.7 pounds)
Reactions: Coronary Artery Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Therapy
Dosage: blinded therapy
Administration route: Oral
Start date: 2011-10-20
Blinded Therapy
Dosage: blinded therapy
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-10-12
End date: 2011-10-19
Brotizolam
Dosage: 0.25 mg, 1x/day
Administration route: Oral
Start date: 2011-04-14
Cabergoline
Dosage: 0.5 mg, 1x/day
Administration route: Oral
Carbidopa
Dosage: unk
Administration route: Oral
Start date: 2007-07-10
Clonazepam
Dosage: 1 mg, 1x/day
Administration route: Oral
Start date: 2007-01-01
Comtan
Dosage: 100 mg, 3x/day
Administration route: Oral
Start date: 2009-06-15
Famotidine
Dosage: 20 mg, 1x/day
Administration route: Oral
Start date: 2011-05-06
Flurbiprofen
Dosage: unk
Administration route: Oral
Start date: 2008-06-19
Gasmotin
Dosage: 5 mg, 2x/day
Administration route: Oral
Magmitt
Dosage: 1650 mg, 3x/day
Administration route: Oral
Start date: 2007-01-01
Symmetrel
Dosage: 50 mg, 2x/day
Administration route: Oral
Start date: 2009-12-21
Tizanidine Hydrochloride
Dosage: unk
Administration route: Oral
Start date: 2007-12-20
Other drugs received by patient: Digoxin
Possible Cabergoline side effects in 65 year old male
Reported by a physician from Italy on 2012-08-14
Patient: 65 year old male
Reactions: ON and Off Phenomenon, Drug Effect Decreased, Chorea, Dependence, Pathological Gambling
Drug(s) suspected as cause:
Cabergoline
Dosage: 8 mg, daily
Indication: Parkinson's Disease
Carbidopa + Levodopa
Dosage: 400/100 mg/d
Indication: Parkinson's Disease
Entacapone
Dosage: 800 mg, daily
Indication: Parkinson's Disease
Finasteride
Dosage: 5 mg, daily
Indication: Benign Prostatic Hyperplasia
Pramipexole Dihydrochloride
Dosage: 3.05 mg, daily
Indication: Parkinson's Disease
Possible Cabergoline side effects in 35 year old female
Reported by a consumer/non-health professional from Colombia on 2012-08-13
Patient: 35 year old female
Reactions: Vomiting, Nausea, Drug Ineffective, Brain Oedema, Dizziness, Headache
Drug(s) suspected as cause:
Cabergoline
Dosage: 0.5 mg, unk
Indication: Blood Prolactin Increased
Start date: 2008-01-01
Dostinex
Dosage: 4 tablets of 0.5 mg inter-day
Administration route: Oral
Dostinex
Dosage: 2 tablets of 0.5 mg inter-day
Administration route: Oral
Indication: Blood Prolactin Increased
Start date: 2008-01-01
Other drugs received by patient: Estrogens; Calcium
Possible Cabergoline side effects in 68 year old female
Reported by a physician from Japan on 2012-08-09
Patient: 68 year old female, weighing 42.2 kg (92.8 pounds)
Reactions: Back Pain, Secondary Adrenocortical Insufficiency, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cabergoline
Dosage: 0.25 mg, weekly
Administration route: Oral
Start date: 2011-03-10
End date: 2011-03-22
Cabergoline
Dosage: 0.5 mg, weekly
Administration route: Oral
Start date: 2011-03-23
End date: 2011-04-05
Cabergoline
Dosage: 0.75 mg, weekly
Administration route: Oral
Start date: 2011-04-06
End date: 2011-04-29
Cabergoline
Dosage: 2 mg, weekly
Administration route: Oral
Start date: 2011-06-08
End date: 2011-08-03
Cabergoline
Dosage: 1 mg, weekly
Administration route: Oral
Start date: 2011-04-20
End date: 2011-05-10
Cabergoline
Dosage: 1.5 mg, weekly
Administration route: Oral
Start date: 2011-05-11
End date: 2011-06-07
Possible Cabergoline side effects in 27 year old female
Reported by a physician from United States on 2012-08-09
Patient: 27 year old female
Reactions: Pneumocephalus
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in
Reported by a physician from United States on 2012-08-07
Patient:
Reactions: Pathological Gambling, Compulsive Shopping
Drug(s) suspected as cause:
Cabergoline
Dosage: 8 mg, / day
Indication: Product Used FOR Unknown Indication
Carbidopa + Levodopa
Dosage: 100/400 mg, / day
Indication: Product Used FOR Unknown Indication
Possible Cabergoline side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-27
Patient: 30 year old female
Reactions: Menstrual Disorder, Galactorrhoea, Prolactinoma, Neoplasm Progression, Drug Interaction
Drug(s) suspected as cause:
Cabergoline
Dosage: 2 mg, twice weekly
Cabergoline
Dosage: 0.25 mg, twice weekly
Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
Dosage: 15 mg, daily
Bromocriptine Mesylate
Dosage: 7.5 mg, daily
Bromocriptine Mesylate
Dosage: 20 mg, daily
Oxcarbazepine
Dosage: 600 mg daily
Indication: Convulsion
Oxcarbazepine
Dosage: 1200 mg daily
Other drugs received by patient: Quinagolide; Quinagolide
Possible Cabergoline side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-27
Patient: 30 year old female
Reactions: Galactorrhoea, Menstrual Disorder, Prolactinoma, Drug Interaction, Neoplasm Progression
Drug(s) suspected as cause:
Cabergoline
Dosage: 0.25 mg, twice weekly
Cabergoline
Dosage: 2 mg, twice weekly
Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
Dosage: 20 mg, daily
Bromocriptine Mesylate
Dosage: 7.5 mg, daily
Bromocriptine Mesylate
Dosage: 15 mg, daily
Oxcarbazepine
Dosage: 600 mg daily
Indication: Convulsion
Oxcarbazepine
Dosage: 1200 mg daily
Other drugs received by patient: Quinagolide; Quinagolide
Possible Cabergoline side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-24
Patient: 65 year old male
Reactions: Irritability, Pathological Gambling, Compulsive Shopping
Drug(s) suspected as cause:
Benserazide, Levodopa
Dosage: 1000 mg/day
Indication: Parkinson's Disease
Cabergoline
Dosage: 8 mg, per day
Indication: Parkinson's Disease
Carbidopa and Levodopa
Indication: Parkinson's Disease
Pramipexole Dihychloride
Dosage: 1.2 mg, per day
Pramipexole Dihychloride
Dosage: 3.05 mg/day
Indication: Parkinson's Disease
Other drugs received by patient: Entacapone
Possible Cabergoline side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-19
Patient: 53 year old male
Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Alprazolam
Dosage: 0.4 mg, 2 in 1 d
Administration route: Oral
Indication: Anxiety Disorder
Cabergoline
Dosage: 1 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Carbidopa
Dosage: 87.5 mg, 6 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-07-20
Comtan
Dosage: 100 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Donepezil HCL
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Start date: 2011-07-05
End date: 2012-06-21
Donepezil HCL
Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-06-23
End date: 2011-07-04
Pramipexole Dihydrochloride
Dosage: 1 mg, 2 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Pramipexole Dihydrochloride
Dosage: 0.25 mg, 1 in 1 d
Administration route: Oral
Start date: 2012-01-18
Seroquel
Dosage: 25 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-21
End date: 2012-06-23
Symmetrel
Dosage: 50 mg, 4 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Zyprexa
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-23
Other drugs received by patient: Rinderon-V
Possible Cabergoline side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-16
Patient: 51 year old male
Reactions: Cardiac Valve Sclerosis
Drug(s) suspected as cause:
Cabergoline
Dosage: 4 mg/day
Cabergoline
Dosage: 26 mg/day
Possible Cabergoline side effects in 68 year old female
Reported by a physician from Japan on 2012-07-16
Patient: 68 year old female, weighing 42.2 kg (92.8 pounds)
Reactions: Back Pain, Secondary Adrenocortical Insufficiency, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cabergoline
Dosage: 0.25 mg, weekly
Administration route: Oral
Indication: Pituitary-Dependent Cushing's Syndrome
Start date: 2011-03-10
End date: 2011-01-01
Cabergoline
Dosage: 2 mg, weekly
Administration route: Oral
Start date: 2011-06-08
Possible Cabergoline side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13
Patient: 53 year old male
Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Alprazolam
Dosage: 0.4 mg, 2 in 1 d
Administration route: Oral
Indication: Anxiety Disorder
Cabergoline
Dosage: 1 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Comtan
Dosage: 100 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Donepezil HCL
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Start date: 2011-07-05
End date: 2012-06-21
Donepezil HCL
Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-06-23
End date: 2011-07-04
Dopacol
Dosage: 87.5 mg, 6 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-07-20
Pramipexole Dihydrochloride
Dosage: 0.25 mg, 1 in 1 d
Administration route: Oral
Start date: 2012-01-18
Pramipexole Dihydrochloride
Dosage: 1 mg, 2 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Seroquel
Dosage: 25 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-21
End date: 2012-06-23
Symmetrel
Dosage: 50 mg, 4 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Zyprexa
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-23
Other drugs received by patient: Rinderon-V
Possible Cabergoline side effects in
Reported by a consumer/non-health professional from Belgium on 2012-07-11
Patient:
Reactions: Congenital Absence of Vertebra, Maternal Exposure Timing Unspecified
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-11
Patient: 53 year old male
Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cabergoline
Dosage: 1 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Comtan
Dosage: 100 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Donepezil HCL
Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-06-23
End date: 2011-07-04
Donepezil HCL
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Start date: 2011-07-05
End date: 2012-06-21
Dopacol
Dosage: 87.5 mg, 6 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-07-20
Pramipexole Dihydrochloride
Dosage: 0.25 mg, 1 in 1 d
Administration route: Oral
Start date: 2012-01-18
Pramipexole Dihydrochloride
Dosage: 1 mg, 2 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Seroquel
Dosage: 25 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-21
End date: 2012-06-23
Symmetrel
Dosage: 50 mg, 4 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Zyprexa
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-23
Other drugs received by patient: Alprazolam; Rinderon-V
Possible Cabergoline side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-10
Patient: 53 year old male
Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cabergoline
Dosage: 1 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Carbidopa + Levodopa
Dosage: 87.5 mg, 6 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-07-20
Comtan
Dosage: 100 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Donepezil HCL
Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-06-23
End date: 2011-07-04
Donepezil HCL
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Start date: 2011-07-05
End date: 2012-06-21
Pramipexole Dihydrochloride
Dosage: 0.25 mg, 1 in 1 d
Administration route: Oral
Start date: 2012-01-18
Pramipexole Dihydrochloride
Dosage: 1 mg, 2 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Seroquel
Dosage: 25 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-21
End date: 2012-06-23
Symmetrel
Dosage: 50 mg, 4 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Zyprexa
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-23
Other drugs received by patient: Rinderon-V; Alprazolam
Possible Cabergoline side effects in female
Reported by a physician from United States on 2012-07-03
Patient: female
Reactions: Insulin-Like Growth Factor Decreased
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 77 year old male
Reported by a pharmacist from Japan on 2012-06-29
Patient: 77 year old male
Reactions: NO Adverse Event
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-26
Patient: 30 year old female
Reactions: Galactorrhoea, Menstrual Disorder, Prolactinoma, Neoplasm Progression, Drug Interaction
Drug(s) suspected as cause:
Cabergoline
Dosage: 0.25 mg, twice weekly
Cabergoline
Dosage: 2 mg, twice weekly
Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
Dosage: 7.5 mg, daily
Bromocriptine Mesylate
Dosage: 15 mg, daily
Bromocriptine Mesylate
Dosage: 20 mg, daily
Oxcarbazepine
Dosage: 1200 mg daily
Oxcarbazepine
Dosage: 600 mg daily
Indication: Convulsion
Other drugs received by patient: Quinagolide; Quinagolide
Possible Cabergoline side effects in 45 year old female
Reported by a physician from United States on 2012-06-26
Patient: 45 year old female
Reactions: Mania
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 77 year old male
Reported by a pharmacist from Japan on 2012-06-26
Patient: 77 year old male
Reactions: Convulsion
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 55 year old male
Reported by a physician from Finland on 2012-06-26
Patient: 55 year old male
Reactions: Therapeutic Response Unexpected, Impulsive Behaviour
Drug(s) suspected as cause:
Cabergoline
Dosage: 1-2 mg, daily
Indication: Parkinson's Disease
Start date: 2002-01-01
Carbidopa + Levodopa
Dosage: 100/25-200/50 mg, daily
Indication: Parkinson's Disease
Start date: 2004-01-01
Selegiline
Dosage: 5 mg, daily
Indication: Parkinson's Disease
Start date: 2001-01-01
Possible Cabergoline side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-26
Patient: 30 year old female
Reactions: Menstrual Disorder, Galactorrhoea, Prolactinoma, Drug Interaction, Neoplasm Progression
Drug(s) suspected as cause:
Cabergoline
Dosage: 0.25 mg, twice weekly
Cabergoline
Dosage: 2 mg, twice weekly
Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
Dosage: 7.5 mg, daily
Bromocriptine Mesylate
Dosage: 20 mg, daily
Bromocriptine Mesylate
Dosage: 15 mg, daily
Oxcarbazepine
Dosage: 600 mg daily
Indication: Convulsion
Oxcarbazepine
Dosage: 1200 mg daily
Other drugs received by patient: Quinagolide; Quinagolide
Possible Cabergoline side effects in 92 year old female
Reported by a pharmacist from Japan on 2012-06-15
Patient: 92 year old female
Reactions: Choking
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 69 year old male
Reported by a pharmacist from Japan on 2012-05-24
Patient: 69 year old male
Reactions: Purpura
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in
Reported by a individual with unspecified qualification from Germany on 2012-05-21
Patient:
Reactions: Mitral Valve Sclerosis, Mitral Valve Prolapse, Mitral Valve Incompetence, Aortic Valve Sclerosis, Tricuspid Valve Sclerosis, Intentional Drug Misuse, Aortic Valve Incompetence
Drug(s) suspected as cause:
Cabergoline
Dosage: 4 mg, / day
Indication: Parkinson's Disease
Cabergoline
Dosage: 26 mg, / day
Possible Cabergoline side effects in 45 year old female
Reported by a consumer/non-health professional from Finland on 2012-05-21
Patient: 45 year old female
Reactions: Bone Loss, Arthralgia, Chest Pain, Insomnia, Feeling Abnormal
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 69 year old male
Reported by a pharmacist from Japan on 2012-05-21
Patient: 69 year old male
Reactions: Haemorrhage, Purpura
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 56 year old male
Reported by a physician from Spain on 2012-05-21
Patient: 56 year old male
Reactions: Pneumocephalus
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cabergoline
|
